BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37337076)

  • 1. Advanced age is an independent prognostic factor of disease progression in high-risk prostate cancer: results in 180 patients treated with robot-assisted radical prostatectomy and extended pelvic lymph node dissection in a tertiary referral center.
    Porcaro AB; Bianchi A; Gallina S; Panunzio A; Serafin E; Mazzucato G; Orlando R; Montanaro F; Patuzzo GM; Baielli A; Artoni F; Ditonno F; Vidiri S; D'Aietti D; Migliorini F; Rizzetto R; Veccia A; Gozzo A; Brunelli M; Tafuri A; Cerruto MA; Antonelli A
    Aging Clin Exp Res; 2023 Sep; 35(9):1881-1889. PubMed ID: 37337076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of prognostic group classification on prostate cancer progression in intermediate-risk patients according to the European Association of Urology system: results in 479 patients treated with robot-assisted radical prostatectomy at a single tertiary referral center.
    Porcaro AB; Bianchi A; Panunzio A; Gallina S; Tafuri A; Serafin E; Orlando R; Mazzucato G; Vidiri S; D'Aietti D; Montanaro F; Marafioti Patuzzo G; Artoni F; Baielli A; Ditonno F; Rizzetto R; Veccia A; Gozzo A; De Marco V; Brunelli M; Cerruto MA; Antonelli A
    Ther Adv Urol; 2024; 16():17562872241229260. PubMed ID: 38348129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of palpable prostate tumors on disease progression after robot-assisted radical prostatectomy: a single-center experience.
    Porcaro AB; Gallina S; Bianchi A; Tafuri A; Serafin E; Panunzio A; Mazzucato G; Orlando R; Ditonno F; Ornaghi PI; Rizzetto R; Cerrato C; De Marco V; Brunelli M; Siracusano S; Cerruto MA; Antonelli A
    J Robot Surg; 2023 Oct; 17(5):2471-2477. PubMed ID: 37486540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous testosterone density is an independent predictor of pelvic lymph node invasion in high-risk prostate cancer: results in 201 consecutive patients treated with radical prostatectomy and extended pelvic lymph node dissection.
    Porcaro AB; Tafuri A; Panunzio A; Mazzucato G; Cerrato C; Gallina S; Bianchi A; Rizzetto R; Amigoni N; Serafin E; Cianflone F; Orlando R; Gentile I; Migliorini F; Zecchini Antoniolli S; Di Filippo G; Brunelli M; Pagliarulo V; Cerruto MA; Antonelli A
    Int Urol Nephrol; 2022 Mar; 54(3):541-550. PubMed ID: 35044553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection in Patients with Locally-advanced Prostate Cancer.
    Gandaglia G; De Lorenzis E; Novara G; Fossati N; De Groote R; Dovey Z; Suardi N; Montorsi F; Briganti A; Rocco B; Mottrie A
    Eur Urol; 2017 Feb; 71(2):249-256. PubMed ID: 27209538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of extended pelvic lymph node dissection on the risk of hospital readmission within 180 days after robot assisted radical prostatectomy.
    Sebben M; Tafuri A; Shakir A; Pirozzi M; Processali T; Rizzetto R; Amigoni N; Tiso L; De Michele M; Panunzio A; Cerrato C; Brunelli M; Migliorini F; Novella G; De Marco V; Siracusano S; Artibani W; Porcaro AB
    World J Urol; 2020 Nov; 38(11):2799-2809. PubMed ID: 31980875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity strongly predicts clinically undetected multiple lymph node metastases in intermediate- and high-risk prostate cancer patients who underwent robot assisted radical prostatectomy and extended lymph node dissection.
    Tafuri A; Amigoni N; Rizzetto R; Sebben M; Shakir A; Gozzo A; Odorizzi K; De Michele M; Gallina S; Bianchi A; Ornaghi P; Brunelli M; De Marco V; Verratti V; Migliorini F; Cerruto MA; Artibani W; Antonelli A; Porcaro AB
    Int Urol Nephrol; 2020 Nov; 52(11):2097-2105. PubMed ID: 32607958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended robot-assisted laparoscopic prostatectomy and extended pelvic lymph node dissection as a monotherapy in patients with very high-risk prostate cancer Patients.
    Miura N; Sugihara N; Funaki K; Kakuda T; Koyama K; Watanabe R; Sawada Y; Noda T; Nishimura K; Fukumoto T; Miyauchi Y; Kikugawa T; Saika T
    Cancer Med; 2021 Nov; 10(22):7968-7976. PubMed ID: 34562303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study.
    Gandaglia G; Mazzone E; Stabile A; Pellegrino A; Cucchiara V; Barletta F; Scuderi S; Robesti D; Leni R; Samanes Gajate AM; Picchio M; Gianolli L; Brembilla G; De Cobelli F; van Oosterom MN; van Leeuwen FWB; Montorsi F; Briganti A
    Eur Urol; 2022 Oct; 82(4):411-418. PubMed ID: 35879127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 2012 Briganti nomogram not only predicts lymph node involvement but also disease progression in surgically treated intermediate-risk prostate cancer patients with PSA <10 ng/mL, ISUP grade group 3, and clinical stage up to cT2b.
    Porcaro AB; Panunzio A; Orlando R; Montanaro F; Baielli A; Artoni F; Gallina S; Bianchi A; Mazzucato G; Serafin E; Patuzzo GM; Veccia A; Rizzetto R; Brunelli M; Migliorini F; Bertolo R; Tafuri A; Cerruto MA; Antonelli A
    Int Braz J Urol; 2024; 50(4):450-458. PubMed ID: 38743063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open approach, extended pelvic lymph node dissection, and seminal vesicle invasion are independent predictors of hospital readmission after prostate cancer surgery: a large retrospective study.
    Sebben M; Tafuri A; Pirozzi M; Processali T; Rizzetto R; Amigoni N; Shakir A; De Michele M; Panunzio A; Cerrato C; Tiso L; Novella G; Brunelli M; Migliorini F; De Marco V; Siracusano S; Artibani W; Porcaro AB
    Minerva Urol Nefrol; 2020 Feb; 72(1):72-81. PubMed ID: 31833722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended versus standard pelvic lymphadenectomy during robot-assisted radical prostatectomy: the role of extended template as an independent predictor of lymph node invasion with comparable morbidity burden.
    Mistretta FA; Boeri L; Grasso AA; Lo Russo V; Albo G; DE Lorenzis E; Maggioni M; Palmisano F; Dell'orto P; Bosari S; Rocco B
    Minerva Urol Nefrol; 2017 Oct; 69(5):475-485. PubMed ID: 28281741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of Lymph Node Invasion in Patients with Clinically Localized Prostate Cancer Who Undergo Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: The Role of Obesity.
    Tafuri A; Rizzetto R; Amigoni N; Sebben M; Shakir A; Gozzo A; Odorizzi K; Gallina S; Bianchi A; Ornaghi P; Brunelli M; Migliorini F; Cerruto MA; Artibani W; Siracusano S; Antonelli A; Porcaro AB
    Urol Int; 2021; 105(5-6):362-369. PubMed ID: 33059351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Adding Sentinel Node Biopsy to Extended Pelvic Lymph Node Dissection on Biochemical Recurrence in Prostate Cancer Patients Treated with Robot-Assisted Radical Prostatectomy.
    Grivas N; Wit EMK; Kuusk T; KleinJan GH; Donswijk ML; van Leeuwen FWB; van der Poel HG
    J Nucl Med; 2018 Feb; 59(2):204-209. PubMed ID: 28747519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced age portends poorer prognosis after radical prostatectomy: a single center experience.
    Porcaro AB; Bianchi A; Gallina S; Serafin E; Mazzucato G; Vidiri S; D'Aietti D; Rizzetto R; Tafuri A; Cerrato C; Panunzio A; Orlando R; Brusa D; Brunelli M; Siracusano S; Cerruto MA; Antonelli A
    Aging Clin Exp Res; 2022 Nov; 34(11):2857-2863. PubMed ID: 35976572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of robot-assisted radical prostatectomy and pelvic lymph node dissection in the management of high-risk prostate cancer: a systematic review.
    Yuh B; Artibani W; Heidenreich A; Kimm S; Menon M; Novara G; Tewari A; Touijer K; Wilson T; Zorn KC; Eggener SE
    Eur Urol; 2014 May; 65(5):918-27. PubMed ID: 23721959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small-volume lymph node involvement and biochemical recurrence after robot-assisted radical prostatectomy with extended lymph node dissection in prostate cancer.
    Morizane S; Honda M; Shimizu R; Teraoka S; Nishikawa R; Tsounapi P; Kimura Y; Iwamoto H; Hikita K; Takenaka A
    Int J Clin Oncol; 2020 Jul; 25(7):1398-1404. PubMed ID: 32333202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Influence of Endogenous Testosterone Density on Unfavorable Disease and Tumor Load at Final Pathology in Intermediate-Risk Prostate Cancer: Results in 338 Patients Treated with Radical Prostatectomy and Extended Pelvic Lymph Node Dissection.
    Porcaro AB; Panunzio A; Tafuri A; Cerrato C; Gallina S; Bianchi A; Rizzetto R; Amigoni N; Gozzo A; Serafin E; Cianflone F; Migliorini F; Vidiri S; Di Filippo G; Novella G; Brunelli M; Shakir A; Pagliarulo V; Cerruto MA; Siracusano S; Antonelli A
    Urol Int; 2022; 106(9):928-939. PubMed ID: 35081537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermediate-term cancer control outcomes in prostate cancer patients treated with robotic-assisted laparoscopic radical prostatectomy: a multi-institutional analysis.
    Abdollah F; Dalela D; Sood A; Sammon J; Jeong W; Beyer B; Fossati N; Rogers CG; Diaz-Insua M; Peabody J; Haese A; Montorsi F; Graefen M; Briganti A; Menon M
    World J Urol; 2016 Oct; 34(10):1357-66. PubMed ID: 26873596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended vs standard lymph node dissection in robot-assisted radical prostatectomy for intermediate- or high-risk prostate cancer: a propensity-score-matching analysis.
    Kim KH; Lim SK; Kim HY; Shin TY; Lee JY; Choi YD; Chung BH; Hong SJ; Rha KH
    BJU Int; 2013 Jul; 112(2):216-23. PubMed ID: 23356436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.